Company / Net Income
Bausch & Lomb Corp Net Income History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Income
-$360.0M
FY2025
5-year range
-$360.0M / $182.0M
FY2021-FY2025
Trend
-13.6%
vs FY2024
Sector context
#144 of 158
Health Care
What the data says
Among 158 Health Care companies, Bausch & Lomb Corp is in the bottom 9% for net income. Net Income has declined for 4 consecutive years, from $182M in FY2021 to -$360M in FY2025.
Based on SEC 10-K filings.
-$360M in FY2025.
Declined from -$260M to -$360M over the past 2 years.
Health Care sector context is included.
Net Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 9% in Health CareTop 91% of 158This company -$360.0M Sector average $458.6M
▼
-178.5% below sector average
Key checks
Key Insights
- Bausch & Lomb Corp's net income has declined for 4 consecutive years.
- In FY2025, net income decreased 13.6% year-over-year.
- Ranks #144 out of 158 companies in the Health Care sector.
- Peak net income was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score 0.74 (distress zone, below 1.8 threshold)
- Negative profit margin: -6.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$360.0M | -13.6% |
| FY2024 | -$317.0M | -21.9% |
| FY2023 | -$260.0M | -4433.3% |
| FY2022 | $6.0M | -96.7% |
| FY2021 | $182.0M | +1111.1% |
| FY2020 | -$18.0M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026